6 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Tonix Pharma Limited | 4 |
| Tonix Pharma Limited | 2 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18271098 | METHODS OF INDUCING IMMUNE TOLERANCE WITH MODIFIED ANTI-CD154 ANTIBODIES | Tonix Pharma Limited | TAYLOR, LIA ELAN | 1641 | Non-Final OA | Jul 06, 2023 |
| 18212500 | CYCLOBENZAPRINE TREATMENT FOR POST-ACUTE SEQUELAE OF (SARS)-CoV-2 INFECTION (PASC) | Tonix Pharma Limited | BARSKY, JARED | 1628 | Non-Final OA | Jun 21, 2023 |
| 18265525 | CYCLOBENZAPRINE TREATMENT FOR FIBROMYALGIA | Tonix Pharma Limited | CHONG, YONG SOO | 1623 | Non-Final OA | Jun 06, 2023 |
| 17638761 | MODIFIED TFF2 POLYPEPTIDES | Tonix Pharma Limited | LIEB, JEANETTE M | 1654 | Non-Final OA | Feb 25, 2022 |
| 17226058 | CYCLOBENZAPRINE TREATMENT FOR SEXUAL DYSFUNCTION | Tonix Pharma Limited | CRAIGO, WILLIAM A | 1615 | Final Rejection | Apr 08, 2021 |
| 17269106 | METHODS OF TREATING ACUTE STRESS DISORDER AND POSTTRAUMATIC STRESS DISORDER | Tonix Pharma Limited | BAEK, BONG-SOOK | 1611 | Non-Final OA | Feb 17, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial